Plasmodium vivax malaria causes significant public health problems in endemic regions.
Considering the rapid spread of drug-resistant parasite strains and the development of …

In Plasmodium vivax, the most studied vaccine antigens are aimed at blocking merozoite
invasion of erythrocytes and disease development. Very few studies have evaluated pre …

Latent forms of Plasmodium vivax, called hypnozoites, cause malaria relapses from the liver
into the bloodstream and are a major obstacle to malaria eradication. To experimentally …

Malaria is a highly prevalent parasitic disease in regions with tropical and subtropical
climates worldwide. Among the species of Plasmodium causing human malaria, P. vivax is …

Malaria is a global health burden, with Plasmodium falciparum (Pf) and Plasmodium vivax
(Pv) responsible for the majority of infections worldwide. Circumsporozoite protein (CSP) is …

The PvCelTOS, PvCyRPA, and Pvs25 proteins play important roles during the three stages
of the P. vivax lifecycle. In this study, we designed and expressed a P. vivax recombinant …

Background P. vivax malaria is a major global health burden hindering social and economic
development throughout many tropical and sub-tropical countries. Pre-erythrocytic (PE) …

The circumsporozoite surface protein (CSP) is the most abundant polypeptide in the
sporozoite covering. This protein is involved in the motility and invasion of the sporozoite …

Malaria, caused by the apicomplexan Plasmodium spp., is a major public health issue that
impacts over one-third of the world's population, with Plasmodium vivax accounting for over …

Plasmodium vivax es una de las especies más ampliamente distribuidas a nivel mundial,
pero desafortunadamente no se ha podido investigar a profundidad los mecanismos de …